Anti-CCR7 antibody [EPR23192-57] - BSA and Azide free,Abcam,AB272938

What is this antibody validated in? Anti-CCR7 antibody [EPR23192-57] - BSA and Azide free (ab272938) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr) in Human, Mouse, Rat samples. Other related products We have a range of other formats of antibody clone [EPR23192-57] also available for your convenience: ab253187 , Carrier free - ab272938, Alexa Fluor® 647 - ab275165 , ab284437, Alexa Fluor® 488 - ab311015 , Alexa Fluor® 594 - ab311781 , Alexa Fluor® 568 - ab313062 , Alexa Fluor® 555 - ab313262 , Alexa Fluor® 750 - ab321499 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. Compatibility This product is compatible with the Maxpar ® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar ® is a trademark of Fluidigm Canada Inc.